Medicines Development for Global Health Limited

Where the EU money came from

Funding by EU programme. Amounts are Medicines Development for Global Health Limited's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• EMINENCEPartner

  Eliminating onchocerciasis with Moxidectin in endemic hotspots of Central Africa

  Horizon Europe · 2025–2030 · Project on CORDIS ↗

  €949ktheir share
• CTCANAssociated partner

  Clinical Trials Community Africa Network

  Horizon Europe · 2023–2025 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Imperial College of Science Technology and MedicineUnited Kingdom · 1 shared project
• Institut de Recherche Pour le DeveloppementFrance · 1 shared project
• Janssen Pharmaceutica NVBelgium · 1 shared project
• Fondation Congolaise Pour la Recherche MedicaleCongo - Brazzaville · 1 shared project
• Fondation MerieuxFrance · 1 shared project
• Association Institut Superieur de Recherche Scientifique et MedicalesCameroon · 1 shared project
• Janssen Cilag SASpain · 1 shared project
• Science for Africa FoundationUnited States · 1 shared project
• Nuvoteq (Pty) LtdSouth Africa · 1 shared project
• Bio Ventures for Global HealthUnited States · 1 shared project
• Johnson & Johnson Services, Inc.United States · 1 shared project
• Janssen Research & Development, LLCUnited States · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• epilepsy
• pandemics
• social sciences
• tropical medicine